Characterizing rhinitis subtypes

American Journal of Rhinology and Allergy

Volumn 27, Issue 6, 2013, Pages 457-460

  Bernstein, Jonathan A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC RHINITIS; ARTICLE; CHRONIC RHINITIS; CYTOLOGY; GENETIC ANALYSIS; HUMAN; PHENOTYPE; QUESTIONNAIRE; RHINITIS; SMELLING; TREATMENT OUTCOME; TREATMENT RESPONSE; VASOMOTOR RHINITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHRONIC DISEASE; HUMANS; MIDDLE AGED; RHINITIS;

EID: 84890937348     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3983     Document Type: Article

References (41)

1. Bellanti JA, and Wallerstedt DB. Allergic rhinitis update: Epidemiology and natural history. Allergy Asthma Proc 21:367-370, 2000.
2. Kaliner MA. Classification of nonallergic rhinitis syndromes with a focus on vasomotor rhinitis, proposed to be known henceforth as nonallergic rhinopathy. World Allergy Organ J 2:98-101, 2009.
3. Derebery J, Meltzer E, Nathan RA, et al. Rhinitis symptoms and comorbidities in the United States: Burden of rhinitis in America survey. Otolaryngol Head Neck Surg 139:198-205, 2008.
4. Nathan RA, Meltzer EO, Derebery J, et al. The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 29:600-608, 2008.
5. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: Results from the pediatric allergies in America survey. J Allergy Clin Immunol 124(suppl 3):S43-S70, 2009.
6. Meltzer EO, Nathan RA, Derebery MJ, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: Findings from the burden of rhinitis in America survey. Allergy Asthma Proc 30:244-254, 2009.
7. Greisner WA III, Settipane RJ, and Settipane GA, Co-existence of asthma and allergic rhinitis: A 23-year follow-up study of college students. Allergy Asthma Proc 19:185-188, 1998.
8. Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 20:209-213, 1999.
9. Meltzer EO, et al. Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific Adult surveys. Allergy Asthma Proc 33(suppl 1):S113-S141, 2012.
10. Anderson GP. Endotyping asthma: New insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372:1107-1119, 2008.
11. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178:218-224, 2008.
12. Di Lorenzo G, Pacor ML, Amodio E, et al. Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms. Int Arch Allergy Immunol 155:263-270, 2011.
13. Bernstein JA. Characteristics of nonallergic vasomotor rhinitis. World Allergy Organ J 2:102-105, 2009.
14. Rezvani M, Brandt D, Bernstein JA, et al. Investigation of olfactory threshold responses in chronic rhinitis subtypes. Ann Allergy Asthma Immunol 99:571-572, 2007.
15. Bernstein JA, Zhang G, Jin L, et al. Olfactory receptor gene polymorphisms and nonallergic vasomotor rhinitis. J Asthma 45:287-292, 2008.
16. Brasch-Andersen C, Haagerup A, Borglum AD, et al. Highly significant linkage to chromosome 3q13.31 for rhinitis and related allergic diseases. J Med Genet 43:e10, 2006.
17. Benson M, Mobini R, Barrenäs F, et al. A haplotype in the inducible T-cell tyrosine kinase is a risk factor for seasonal allergic rhinitis. Allergy 64:1286-1291, 2009.
18. Hussein YM, Ahmad AS, Ibrahem MM, et al. Interferon gamma gene polymorphism as a biochemical marker in Egyptian atopic patients. J Investig Allergol Clin Immunol 19:292-298, 2009.
19. Settipane RA, and Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 86:494-507, 2001.
20. Brandt D, and Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol 96:526-532, 2006.
21. Brandt D, and Bernstein JA. Questionnaire diagnosis of nonallergic rhinitis. Clin Allergy Immunol 19:55-67, 2007.
22. Bernstein JA. Allergic and mixed rhinitis: Epidemiology and natural history. Allergy Asthma Proc 31:365-369, 2010.
23. Bernstein JA, Levin LS, Al-Shuik E, and Martin VT. Clinical characteristics of chronic rhinitis patients with high vs low irritant trigger burdens. Ann Allergy Asthma Immunol 109:173-178, 2012.
24. Rondón C, Campo P, Galindo L, et al. Prevalence and clinical relevance of local allergic rhinitis. Allergy 67:1282-1288, 2012.
25. Rondón C, Campo P, Togias A, et al. Local allergic rhinitis: Concept, pathophysiology, and management. J Allergy Clin Immunol 129:1460-1467, 2012.
26. Gelardi M, Fiorella ML, Russo C, et al. Role of nasal cytology. Int J Immunopathol Pharmacol 23(suppl):45-49, 2010.
27. Gratzious C, Rovina N, Makris M, et al. Breath markers of oxidative stress and airway inflammation in seasonal allergic rhinitis. Int J Immunopathol Pharmacol 21:949-957, 2008.
28. Kalpaklioglu AF, and Kalkan IK. Comparison of orally exhaled nitric oxide in allergic versus nonallergic rhinitis. Am J Rhinol Allergy 26:e50-e54, 2012.
29. Scadding G, and Scadding GK. Update on the use of nitric oxide as a noninvasive measure of airways inflammation. Rhinology 47:115-120, 2009.
30. Timperley D, Srubisky A, Stow N, et al. Minimal clinically important differences in nasal peak inspiratory flow. Rhinology 49:37-40, 2011.
31. Uzzaman A, Metcalfe DD, and Komarow HD, Acoustic rhinometry in the practice of allergy. Ann Allergy Asthma Immunol 97:745-751, 2006.
32. Bernstein JA, Salapatek AM, Lee JS, et al. Provocation of nonallergic rhinitis subjects in response to simulated weather conditions using an environmental exposure chamber model. Allergy Asthma Proc 33:333-340, 2012.
33. Jacobs RI, Harper N, He W, et al. Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes. J Allergy Clin Immunol 130:122-127.e8, 2012.
34. Tantilipikorn P, Thanaviratananich S, Chusakul S, et al. Efficacy and safety of once daily fluticasone furoate nasal spray for treatment of irritant (non-allergic) rhinitis. Open Respir Med J 4:92-99, 2010.
35. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122(suppl):S1-S84, 2008.
36. Banov CH, Lieberman P, and the Vasomotor Rhinitis study. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 86:28-35, 2001.
37. Carr W, Bernstein J, Lieberman P, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol 129:1282-1289.e10, 2012.
38. Smith AM, Rezvani M, and Bernstein JA. Is response to allergen immunotherapy a good phenotypic marker for differentiating between allergic rhinitis and mixed rhinitis? Allergy Asthma Proc 32:49-54, 2011.
39. Becker B, Borum S, Nielsen K, et al. A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhea in patients with perennial non-allergic rhinitis. Clin Otolaryngol Allied Sci 22:132-134, 1997.
40. Bernstein JA. Nonallergic rhinitis: Therapeutic options. Curr Opin Allergy Clin Immunol 13:410-416, 2013.
41. Settipane RA, and Charnock DR. Epidemiology of rhinitis: Allergic and nonallergic. Clin Allergy Immunol 19:23-34, 2007.